Bruce A. Warden

1.6k total citations · 1 hit paper
35 papers, 1.0k citations indexed

About

Bruce A. Warden is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Bruce A. Warden has authored 35 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 17 papers in Cardiology and Cardiovascular Medicine and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Bruce A. Warden's work include Lipoproteins and Cardiovascular Health (18 papers), Lipid metabolism and disorders (8 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). Bruce A. Warden is often cited by papers focused on Lipoproteins and Cardiovascular Health (18 papers), Lipid metabolism and disorders (8 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). Bruce A. Warden collaborates with scholars based in United States, Australia and Canada. Bruce A. Warden's co-authors include Ashley Chen, Eric C. Stecker, P. Barton Duell, Sergio Fazio, Michael D. Shapiro, Cezary Wójcik, Jessica Minnier, Jonathan Q. Purnell, Jon P. Furuno and Joshua Miles and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Bruce A. Warden

33 papers receiving 1.0k citations

Hit Papers

Direct Oral Anticoagulant Use: A Practical Guide to Commo... 2020 2026 2022 2024 2020 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruce A. Warden United States 16 504 417 206 147 142 35 1.0k
Tomasz Fabiszak Poland 20 629 1.2× 393 0.9× 83 0.4× 110 0.7× 189 1.3× 61 1.2k
Simon de Denus Canada 24 1.1k 2.2× 383 0.9× 147 0.7× 136 0.9× 180 1.3× 96 1.9k
Susan R. Heckbert United States 14 422 0.8× 201 0.5× 215 1.0× 59 0.4× 127 0.9× 24 946
Yuyin Liu United States 18 576 1.1× 378 0.9× 131 0.6× 47 0.3× 202 1.4× 67 1.2k
Miłosz Jankowski Poland 18 416 0.8× 417 1.0× 161 0.8× 86 0.6× 71 0.5× 50 1.5k
José María Mostaza Spain 24 701 1.4× 865 2.1× 143 0.7× 284 1.9× 422 3.0× 138 1.7k
J. Ycas United States 11 550 1.1× 512 1.2× 158 0.8× 126 0.9× 157 1.1× 24 1.0k
Heinz Drexel Austria 17 454 0.9× 255 0.6× 50 0.2× 77 0.5× 238 1.7× 51 1.2k
Gunnar Brandrup‐Wognsen Sweden 16 848 1.7× 668 1.6× 66 0.3× 151 1.0× 193 1.4× 44 1.3k
Sheryl L. Chow United States 16 758 1.5× 195 0.5× 82 0.4× 42 0.3× 179 1.3× 43 1.3k

Countries citing papers authored by Bruce A. Warden

Since Specialization
Citations

This map shows the geographic impact of Bruce A. Warden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce A. Warden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce A. Warden more than expected).

Fields of papers citing papers by Bruce A. Warden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce A. Warden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce A. Warden. The network helps show where Bruce A. Warden may publish in the future.

Co-authorship network of co-authors of Bruce A. Warden

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce A. Warden. A scholar is included among the top collaborators of Bruce A. Warden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce A. Warden. Bruce A. Warden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Warden, Bruce A. & P. Barton Duell. (2025). Real-world evaluation of bempedoic acid use in patients with homozygous familial hypercholesterolemia. Journal of clinical lipidology. 20(1). 96–103.
2.
Safarova, Maya, Lara Kovell, Bruce A. Warden, et al.. (2025). Statin Use in Special Populations for the Prevention of Cardiovascular Disease in Adults. Current Atherosclerosis Reports. 27(1). 54–54. 3 indexed citations
3.
Rossi, Laura, Bradi B. Granger, Jeffrey Bruckel, et al.. (2023). Person-Centered Models for Cardiovascular Care: A Review of the Evidence: A Scientific Statement From the American Heart Association. Circulation. 148(6). 512–542. 12 indexed citations
4.
Warden, Bruce A., John R. Guyton, Laney K. Jones, et al.. (2022). Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association. Journal of clinical lipidology. 17(1). 19–39. 60 indexed citations
5.
Warden, Bruce A., et al.. (2021). Real-world utilization of bempedoic acid in an academic preventive cardiology practice. Journal of clinical lipidology. 16(1). 94–103. 22 indexed citations
6.
Warden, Bruce A., et al.. (2021). Optimizing sodium-glucose co-transporter 2 inhibitor use in patients with heart failure with reduced ejection fraction: A collaborative clinical practice statement. SHILAP Revista de lepidopterología. 6. 100183–100183. 4 indexed citations
7.
Oleaga, Carlota, Michael D. Shapiro, Joshua Hay, et al.. (2021). Hepatic Sensing Loop Regulates PCSK9 Secretion in Response to Inhibitory Antibodies. Journal of the American College of Cardiology. 78(14). 1437–1449. 20 indexed citations
8.
Warden, Bruce A., et al.. (2021). Real-world utilization of pharmacotherapy with new evidence-based cardiovascular indications in an academic preventive cardiology practice. SHILAP Revista de lepidopterología. 5. 100144–100144. 7 indexed citations
9.
Warden, Bruce A., Carlota Oleaga, Om P. Ganda, et al.. (2020). Unusual Responses to PCSK9 Inhibitors in a Real-world Clinical Cohort. SHILAP Revista de lepidopterología. 3. 100042–100042. 1 indexed citations
10.
Warden, Bruce A., Jessica Minnier, P. Barton Duell, Sergio Fazio, & Michael D. Shapiro. (2020). Chylomicronemia syndrome: Familial or not?. Journal of clinical lipidology. 14(2). 201–206. 28 indexed citations
11.
Warden, Bruce A., et al.. (2020). Use of PCSK9 Inhibitors in Solid Organ Transplantation Recipients. SHILAP Revista de lepidopterología. 2(3). 396–399. 16 indexed citations
12.
Warden, Bruce A., Joshua Miles, Carlota Oleaga, et al.. (2020). Unusual responses to PCSK9 inhibitors in a clinical cohort utilizing a structured follow-up protocol. SHILAP Revista de lepidopterología. 1. 100012–100012. 14 indexed citations
13.
Chen, Ashley, Eric C. Stecker, & Bruce A. Warden. (2020). Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges. Journal of the American Heart Association. 9(13). e017559–e017559. 407 indexed citations breakdown →
14.
Warden, Bruce A., Sergio Fazio, & Michael D. Shapiro. (2019). The PCSK9 revolution: Current status, controversies, and future directions. Trends in Cardiovascular Medicine. 30(3). 179–185. 70 indexed citations
15.
Warden, Bruce A. & P. Barton Duell. (2019). Management of dyslipidemia in adult solid organ transplant recipients. Journal of clinical lipidology. 13(2). 231–245. 40 indexed citations
16.
Warden, Bruce A., Jessica Minnier, Gerald F. Watts, Sergio Fazio, & Michael D. Shapiro. (2019). Impact of PCSK9 inhibitors on plasma lipoprotein(a) concentrations with or without a background of niacin therapy. Journal of clinical lipidology. 13(4). 580–585. 16 indexed citations
17.
Warden, Bruce A. & P. Barton Duell. (2018). Volanesorsen for treatment of patients with familialchylomicronemia syndrome. Drugs of today. 54(12). 721–721. 15 indexed citations
18.
Warden, Bruce A., et al.. (2015). Risk of thromboembolic events after protocolized warfarin reversal with 3-factor PCC and factor VIIa. The American Journal of Emergency Medicine. 33(11). 1562–1566. 12 indexed citations
19.
Bubalo, Joseph, et al.. (2013). Does applying technology throughout the medication use process improve patient safety with antineoplastics?. Journal of Oncology Pharmacy Practice. 20(6). 445–460. 29 indexed citations
20.
Warden, Bruce A., et al.. (2012). Antithrombotics for secondary prevention of noncardioembolic ischaemic stroke. Nature Reviews Neurology. 8(4). 223–235. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026